510(k) Report

PMA · Approved

Approved

EPi-Sense Guided Coagulation System

P200002PMAApproved Apr 28, 2021482-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

AtriCure, Inc. · OCM Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation

Approved on Apr 28, 2021 through premarket approval, which rests on the device’s own clinical evidence after a 482-day review.

Decided
Apr 28, 2021
Review
482 days
Class
Class III
Product code
OCM
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P200002 has 15 supplements since 2022: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2022: 42023: 42024: 12025: 42026: 2
2022high 4 (2022) · low 1 (2024)2026
View FIG. 1 as a table
YearSupplements approved
20224
20234
20241
20254
20262
FIG. 1 — Supplements to P200002, 2022–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OCM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All OCM devices

OCM Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · OCM

5in 2025

2011: 12012: 12013: 12014: 22015: 22016: 22018: 12019: 12020: 22021: 12022: 52023: 72024: 22025: 52026 (partial year): 4
2007high 7 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OCM

Too few OCM 510(k)s in any year since 2007 to give a median.

Recalls per year · OCM

No recall names OCM since 2007.

Adverse event reports per year · OCM

10in 2025

2012: 12015: 12016: 32017: 42018: 52019: 102020: 12021: 62022: 52023: 32024: 162025: 10
2007high 16 (2024) · low 0 (2007)2025

MAUDE reports naming product code OCM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20111—00
20121—01
20131—00
20142—00
20152—01
20162—03
20170—04
20181—05
20191—010
20202—01
20211—06
20225—05
20237—03
20242—016
20255—010
20264—0—
Cite this page

510(k) Report. “P200002: EPi-Sense Guided Coagulation System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/P200002

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026